Cancer cytopathologyHumansCarcinomaPancreatic DuctalSmad4 ProteinPancreatic Neoplasms
Diagnostic utility of p53, SMAD4, and the novel biomarker PON2 in FNA of pancreatic ductal adenocarcinoma.
Ruimeng Yang, Catherine Gereg, Maria C Olave, Esther Yoon, Guoping Cai
Published: 202510.1002/cncy.70058
Abstract
BACKGROUND: Accurate cytologic diagnosis of pancreatic ductal adenocarcinoma (PDAC) remains challenging. In this retrospective study, the authors assessed the utility of p53, SMAD4, and paraoxonase-2 (PON2) expression in fine-needle aspiration (FNA)…
Preview only. Read the full abstract at the source